权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

The pharmacological relevance of pro-peptide of GDNF family members

GDNF家族成员前肽的药理学相关性

基本信息

批准号：
1800648
负责人：
金额：
--
依托单位：
University of Cambridge
依托单位国家：
英国
项目类别：
Studentship
财政年份：
2016
资助国家：
英国
起止时间：
2016 至无数据
项目状态：
已结题

来源：
https://gtr.ukri.org/projects?ref=studentship-1800648
关键词：
pharmacological relevance pro peptide GDNF

项目摘要

Theme: Bioscience for HealthType 2 Diabetes and metabolic diseases more generally together with cardiovascular diseases affect increasing numbers of people. There is interest in regenerative approaches for both pancreaticbeta-cells and cardiomyocytes. TGFbfamily proteins play an important part in cell development and differentiation as well as in disease and BMP2 has been successfully developed and is marketed as a regenerative factor for bone growth. GDNF subfamily of growth factors are normally used as neurotrophic factors, but neurturin in particular has been shown to have beneficial effect on diabetic animals, lowering their glucose levels in insulin dependent manner. While the mechanism for this is unknown, the use of neurturin as therapeutic agent is compromised by its poor pharmacodynamic properties and limited tissue distribution. As neurturin, like all GDNF-like proteins, is synthesised as larger precursors. We have recently shown how activin A has very different properties when complexed with its pro-peptide. We hypothesise that the precursor forms of neurturin are similarly different from the mature protein so far used in the assessment of therapeutic potential. The aim of this project is to produce pre-cursor forms of neurturin and analyse its biochemical, biological and structural activities. At the same time we will analyse the effect of the pro-peptide on the bioavailability and tissue distribution of the growth factor, with an aim of developing more effective therapeutic agents.

主题：促进健康的生物科学2型糖尿病和更普遍的代谢性疾病以及心血管疾病影响越来越多的人。人们对胰岛细胞和心肌细胞的再生方法很感兴趣。tgfb家族蛋白在细胞发育和分化以及疾病中发挥重要作用，BMP2已成功开发并作为骨生长的再生因子上市。生长因子的GDNF亚家族通常被用作神经营养因子，但神经turin已被证明对糖尿病动物具有有益作用，以胰岛素依赖的方式降低其葡萄糖水平。虽然其机制尚不清楚，但由于其较差的药效学特性和有限的组织分布，神经turin作为治疗剂的使用受到损害。像所有gdnf样蛋白质一样，神经转蛋白被合成为更大的前体。我们最近展示了激活素A与它的前肽络合时具有非常不同的性质。我们假设神经蛋白的前体形式与迄今为止用于治疗潜力评估的成熟蛋白类似地不同。该项目的目的是产生前游标形式的神经蛋白，并分析其生化，生物学和结构活性。同时，我们将分析前肽对生长因子的生物利用度和组织分布的影响，以开发更有效的治疗药物。